| 2025-12-03 |
详情>>
内部人交易：
Stergiou Angelos M.等共交易3笔
|
| 2025-11-12 |
详情>>
股本变动：
变动后总股本14244.22万股
|
| 2025-11-12 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-0.2美元,归母净利润-1920.5万美元,同比去年增长20.46%
|
| 2025-08-12 |
详情>>
业绩披露：
2025年中报每股收益-0.13美元,归母净利润-1241.4万美元,同比去年增长27.13%
|
| 2025-05-20 |
股东大会：
将于2025-06-24召开股东大会
会议内容 ▼▲
- 1.To receive and consider the audited consolidated financial statements of the Company for the financial year ended December 31, 2024, and the auditors’ report thereon;
2.To elect directors of the Company for the ensuing year;
3.To appoint KPMG LLP, Chartered Professional Accountants, as auditors of the Company until the next annual general meeting and to authorise the board of directors to set their remuneration;
4.To transact such other business as may properly be brought before the Meeting and any adjournment or postponement thereof.
|
| 2025-05-13 |
详情>>
业绩披露：
2025年一季报每股收益-0.07美元,归母净利润-581.3万美元,同比去年增长39.23%
|
| 2025-04-23 |
股东大会：
将于2025-06-17召开股东大会
会议内容 ▼▲
- 1.To elect two Class III directors to serve on our Board of Directors for a three-year term expiring on the date on which our annual meeting of stockholders is held in 2028;
2.To ratify the appointment by our Audit Committee of Moss Adams LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025;
3.To approve an amendment to the Company’s 2021 Employee Stock Purchase Plan (“ESPP”) to increase the number of shares of Common Stock available for sale under the ESPP by 800,000;
4.To approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers.
5.To recommend, on a non-binding advisory basis, the frequency of future advisory votes on the compensation of the Company’s named executive officers;
6.To approve any postponement or adjournment of the 2025 Annual Meeting, from time to time, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the 2025 Annual Meeting to adopt the proposals set forth above or to establish a quorum.
|
| 2025-03-20 |
详情>>
业绩披露：
2024年年报每股收益-0.5美元,归母净利润-3088.1万美元,同比去年增长17.30%
|
| 2024-11-13 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.42美元,归母净利润-2414.4万美元,同比去年增长17.33%
|
| 2024-08-13 |
详情>>
业绩披露：
2024年中报每股收益-0.33美元,归母净利润-1703.6万美元,同比去年增长14.55%
|
| 2024-05-14 |
详情>>
业绩披露：
2024年一季报每股收益-0.21美元,归母净利润-956.6万美元,同比去年增长13.80%
|
| 2024-04-29 |
股东大会：
将于2024-06-20召开股东大会
会议内容 ▼▲
- 1.To elect two Class II directors to serve on our Board of Directors for a three-year term expiring on the date on which our annual meeting of stockholders is held in 2027;
2.To ratify the appointment by our Audit Committee of Moss Adams LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024;
3.To approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers.
|
| 2024-03-28 |
详情>>
业绩披露：
2023年年报每股收益-1.34美元,归母净利润-3734万美元,同比去年增长9.59%
|
| 2023-11-09 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-1.09美元,归母净利润-2920.4万美元,同比去年增长9.25%
|
| 2023-08-10 |
详情>>
业绩披露：
2023年中报每股收益-0.77美元,归母净利润-1993.7万美元,同比去年增长20.75%
|
| 2023-04-28 |
股东大会：
将于2023-06-20召开股东大会
会议内容 ▼▲
- 1.To elect two (2) Class I directors to serve on our Board of Directors for a three-year term expiring on the date on which our annual meeting of stockholders is held on 2026.
2.To ratify the appointment by our Audit Committee of Moss Adams LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023.
3.To approve an amendment to the Company’s 2019 Equity Incentive Plan (the “2019 Equity Plan”) to increase the number of shares of Common Stock authorized for issuance under the 2019 Equity Plan by 3,000,000 shares and to delete the reference to the evergreen provision which expired on January 2, 2023 from the 2019 Equity Plan.
4.To approve a proposed amendment to the Company’s Amended and Restated Certificate of Incorporation to reflect new Delaware law provisions regarding officer exculpation.
5.To approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers.
6.To transact such other business as may be properly brought before the annual meeting and any adjournment or postponement thereof.
|
| 2022-04-25 |
股东大会：
将于2022-06-08召开股东大会
会议内容 ▼▲
- 1.To elect two Class III directors to serve on our Board of Directors for a three-year term expiring on the date on which our annual meeting of stockholders is held in 2025;
2.To ratify the appointment by our Audit Committee of Moss Adams LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022;
3.To approve, on a non-binding, advisory basis, the compensation of our named executive officers;
4.To transact such other business as may properly come before the 2022 Annual Meeting and any adjournment or postponement thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-23 |
股东大会：
将于2021-06-08召开股东大会
会议内容 ▼▲
- 1.To elect one Class II director to serve on our Board of Directors for a three-year term expiring on the date on which our annual meeting of stockholders is held in 2024;
2.To ratify the appointment by our Audit Committee of Moss Adams LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2021;
3.To approve, on a non-binding, advisory basis, the compensation of our named executive officers
4.To approve the 2021 Employee Stock Purchase Plan;
5.To transact such other business as may properly come before the 2021 Annual Meeting and any adjournment or postponement thereof.
|
| 2020-12-11 |
复牌提示：
2020-12-10 15:00:40 停牌，复牌日期 2020-12-10 15:05:40
|
| 2020-06-03 |
股东大会：
将于2020-06-09召开股东大会
会议内容 ▼▲
- 1.To elect three Class I directors to serve on our Board of Directors, each for a three-year term expiring on the date on which our annual meeting of stockholders is held in 2023;
2.To ratify the appointment by our Audit Committee of Moss Adams LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2020;
3.To approve, on a non-binding, advisory basis, the compensation of our named executive officers;
4.To transact such other business as may properly come before the 2020 Annual Meeting and any adjournment or postponement thereof.
|
| 2019-11-06 |
详情>>
拆分方案：
每50.0000合并分成1.0000股
|
| 2019-08-05 |
股东大会：
将于2019-09-10召开股东大会
会议内容 ▼▲
- 1.To adopt and approve an amendment to our Amended and Restated Certificate of Incorporation that effects a Reverse Stock Split at a ratio of not less than 1-for-20 and not greater than 1-for-60, with the exact ratio and effective time of the Reverse Stock Split to be determined by the Board at any time within one year of the date of the Special Meeting.
2.To approve the Company’s 2019 Equity Incentive Plan.
3.To approve an adjournment of the Special Meeting, if necessary, to solicit additional proxies in favor of the Reverse Stock Split proposal and the 2019 Equity Plan proposal.
|
| 2019-05-24 |
股东大会：
将于2019-07-12召开股东大会
会议内容 ▼▲
- 1.To elect one Class III director to serve on our Board of Directors for a three-year term expiring on the date on which our annual meeting of stockholders is held in 2022;
2.To approve, on an advisory basis, the compensation of our named executive officers;
3.To recommend, by non-binding vote, the frequency of future stockholder advisory votes to approve the compensation of our named executive officers;
4.To ratify the selection by our Audit Committee of Moss Adams LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2019;
5.To transact such other business as may properly come before the annual meeting and any adjournment or postponement thereof.
|
| 2018-11-15 |
财报披露：
美东时间 2018-11-15 盘前发布财报
|
| 2018-05-01 |
股东大会：
将于2018-06-12召开股东大会
会议内容 ▼▲
- 1.To elect two (2) Class II directors to serve on our Board of Directors for three-year terms.
2.To ratify the selection by our Audit Committee of Moss Adams LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2018.
3.To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the accompanying proxy statement, or Proxy Statement.
4.To conduct any other business properly brought before the Annual Meeting and any adjournment or postponement thereof.
|
| 2018-04-06 |
股东大会：
将于2018-04-25召开股东大会
会议内容 ▼▲
- 1.To approve, as required by and in accordance with Nasdaq Listing Rule 5635(d), the issuance of securities that are potentially convertible into or exercisable for greater than 20% of our pre-transaction outstanding common stock, in a private placement, at a price less than the greater of book or market value, which securities consist of:
1.1an aggregate of 1,844,835 shares of our common stock, par value $0.0001 per share, issuable upon conversion of shares of our non-voting Series A 20% convertible preferred stock, or the Series A preferred, issued or issuable pursuant to the Securities Purchase Agreement dated March 7, 2018, or the Purchase Agreement, as set forth in further detail in the accompanying proxy statement;
1.2an aggregate of 1,383,631 shares of our common stock issuable exercise of warrants issued or issuable pursuant to the Purchase Agreement, as set forth in further detail in the accompanying proxy statement;
1.3any additional shares of our common stock that may be issuable pursuant to the terms of the Series A preferred and warrants, all as set forth in further detail in the accompanying proxy statement;
2.To conduct any other business properly brought before the annual meeting and any adjournment or postponement thereof
|
| 2017-12-29 |
详情>>
拆分方案：
每30.0000合并分成1.0000股
|
| 2017-08-14 |
财报披露：
美东时间 2017-08-14 盘后发布财报
|
| 2017-06-09 |
股东大会：
将于2017-07-06召开股东大会
会议内容 ▼▲
- 1.To ratify the filing and effectiveness of the certificate of amendment to our amended and restated certificate of incorporation (as amended) (our “Certificate of Incorporation”) filed with the Secretary of State of the State of Delaware (the “Secretary of State”) on July 26, 2011 (the “2011 Share Increase Amendment”) and the increase in the number of shares of authorized common stock effected thereby (the “2011 Share Increase Amendment Ratification”).
2.To ratify the filing and effectiveness of the certificate of amendment to our Certificate of Incorporation filed with the Secretary of State on June 28, 2013 (the “2013 Share Increase Amendment”) and the increase in the number of shares of authorized common stock effected thereby (the “2013 Share Increase Amendment Ratification”).
3.To ratify the filing and effectiveness of the certificate of amendment to our Certificate of Incorporation filed with the Secretary of State on June 19, 2015 (the “2015 Share Increase Amendment”) and the increase in the number of shares of authorized common stock effected thereby (the “2015 Share Increase Amendment Ratification”).
4.To ratify the filing and effectiveness of the certificate of amendment to our Certificate of Incorporation filed with the Secretary of State on October 17, 2016 (the “2016 Share Increase Amendment” and, together with the 2011 Share Increase Amendment, the 2013 Share Increase Amendment and the 2015 Share Increase Amendment, the “Share Increase Amendments”) and the increase in the number of shares of authorized common stock effected thereby (the “2016 Share Increase Amendment Ratification” and, together with the 2011 Share Increase Amendment Ratification, the 2013 Share Increase Amendment Ratification and the 2015 Share Increase Amendment Ratification, the “Share Increase Amendment Ratifications”).
5.To ratify the filing and effectiveness of the certificate of amendment to our Certificate of Incorporation filed with the Secretary of State on November 2, 2016 (the “Reverse Stock Split Amendment”) and the 1-for-20 reverse stock split effected thereby (“Reverse Stock Split Amendment Ratification” and, together with the Share Increase Amendment Ratifications, the “Ratifications”).
6.To approve an adjournment of the Special Meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of any of the Ratifications.
|
| 2017-04-20 |
股东大会：
将于2017-06-08召开股东大会
会议内容 ▼▲
- 1.To elect three directors to serve until the 2020 annual meeting of stockholders;
2.To approve, by non-binding vote, the compensation of our named executive officers;
3.To ratify the appointment of Moss Adams (“Moss Adams”) as our independent registered public accounting firm for 2017;
4.To conduct any other business properly brought before the Annual Meeting.
|
| 2016-10-31 |
详情>>
拆分方案：
每20.0000合并分成1.0000股
|
| 2016-09-21 |
股东大会：
将于2016-10-21召开股东大会
会议内容 ▼▲
- 1. To approve an amendment to the Company’s Amended and Restated Certificate of Incorporation (as amended from time to time, the “Charter”), to effect a reverse stock split of the outstanding shares of the Company’s common stock, par value $0.0001 per share (the “common stock”), at a ratio of not less than 1 for 2 and not greater than 1 for 20, with the exact ratio and effective time of the reverse stock split to be determined by the Board of Directors (the “Reverse Stock Split”) and publicly announced by press release.
2. To authorize the issuance shares of the Company’s common stock issuable upon the redemption, conversion or other satisfaction of the Company’s obligations under its Amended and Restated 9% Original Issue Discount Senior Secured Debenture due November 10, 2018, without the need for any limitation or cap on issuances as required by and in accordance with NASDAQ Marketplace Rule 5635(d).
3. To authorize the adjournment of the Special Meeting, if necessary or appropriate, if a quorum is present, to solicit additional proxies if there are insufficient votes at the Special Meeting in favor of the Reverse Stock Split;
4. To transact any other business that may properly come before the Special Meeting.
|
| 2016-06-03 |
股东大会：
将于2016-07-14召开股东大会
会议内容 ▼▲
- 1.To elect two directors to serve until the 2019 annual meeting of stockholders;
2.To approve an increase in our authorized common stock;
3.To approve the Galena Biopharma, Inc. 2016 Incentive Plan (the “2016 Incentive Plan”);
4.To approve, by non-binding vote, the compensation of our named executive officers;
5.To ratify the appointment of Moss Adams (“Moss Adams”) as our independent registered public accounting firm for 2016;
6.To conduct any other business properly brought before the Annual Meeting.
|